Figure 2 — Allicin treats myocardial infarction in I/R through the promotion of the SHP2 axis to inhibit p-PERK-mediated oxidative stress

Research Paper|Volume 16, Issue 6|pp. 5207–5223

Allicin treats myocardial infarction in I/R through the promotion of the SHP2 axis to inhibit p-PERK-mediated oxidative stress

Back to articleFigure 2(2 of 8)

100%

Figure 2.Size of myocardial infarction in TTC-stained mice. (A) TTC staining of the hearts in each group. (B) Statistical data on the ratio of TTC-positive area. One-way analysis, **p < 0.01, n = 6/group.